Corindus Vascular Robotics Reached An Inflection Point

  • Growth of its CorPath GRX robotics system is taking off as physician and patient acceptance is growing, with revenue doubling from a year ago from a small base.
  • Growth is likely to continue sequentially on this market acceptance and the company has multiple growth avenues in front of it.
  • Especially promising is the exponential growth in demand for cassettes from its growing installed base.
  • A path to profitability is present, but there isn’t much hard data to assess its time frame and more dilution seems likely.

Source: Corindus Vascular Robotics Reached An Inflection Point – Corindus Vascular Robotics, Inc. (NYSEMKT:CVRS) | Seeking Alpha